Atai Life Sciences Income After Taxes 2020-2024 | ATAI
Atai Life Sciences income after taxes from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Atai Life Sciences Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $-40 |
| 2022 | $-141 |
| 2021 | $-133 |
| 2020 | $-102 |
| 2019 | $-17 |
| Atai Life Sciences Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-57 |
| 2024-03-31 | $-26 |
| 2023-12-31 | $-19 |
| 2023-09-30 | $44 |
| 2023-06-30 | $-32 |
| 2023-03-31 | $-33 |
| 2022-12-31 | $-45 |
| 2022-09-30 | $-33 |
| 2022-06-30 | $-31 |
| 2022-03-31 | $-32 |
| 2021-12-31 | $-44 |
| 2021-09-30 | $-27 |
| 2021-06-30 | $-67 |
| 2021-03-31 | $6 |
| 2020-12-31 | $-92 |
| 2020-09-30 | $-21 |
| 2020-06-30 | $-7 |
| 2020-03-31 | $18 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.265B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.039B | 12.12 |
| Quest Diagnostics (DGX) | United States | $17.877B | 18.12 |
| DaVita (DVA) | United States | $12.667B | 16.38 |
| Encompass Health (EHC) | United States | $10.405B | 24.53 |
| Chemed (CHE) | United States | $8.459B | 26.00 |
| Elanco Animal Health (ELAN) | United States | $7.054B | 16.79 |
| RadNet (RDNT) | United States | $6.388B | 141.61 |
| Option Care Health (OPCH) | United States | $3.890B | 18.43 |
| Amedisys (AMED) | United States | $3.035B | 21.60 |
| LifeStance Health (LFST) | United States | $2.828B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.320B | 27.22 |
| Astrana Health (ASTH) | United States | $2.297B | 36.01 |
| U.S Physical Therapy (USPH) | United States | $1.428B | 37.54 |
| Pennant (PNTG) | United States | $1.162B | 46.99 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.149B | 0.00 |
| Daxor (DXR) | United States | $0.042B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.011B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |